eMedicine Specialties > Radiology > Genitourinary
Angiomyolipoma, Kidney: Imaging
Updated: Feb 3, 2009
Radiography
Findings
Renal ultrasonogram obtained in a 12-year-old boy with known tuberous sclerosis. Note the multiple echogenic tumors of varying sizes in both kidneys (see also Images below). This oblique sagittal scan through the left kidney shows a 4-cm echogenic mass (arrow) on the inferior aspect of the kidney that anteriorly displaces the renal sinus (S).
Renal ultrasonogram depicting many tumors in the right kidney. The arrow marks an echogenic 1-cm lesion. (Image above and 2 below were obtained in the same patient.)
Selective right renal angiogram showing multiple avascular tumors. The tumors are small. (Images above and one below were obtained in the same patient.)
Selective left renal angiogram showing 2 tumors, which are larger than those in Image 3. The final diagnosis was multiple renal angiomyolipomas in a patient with tuberous sclerosis. (Images above were obtained in the same patient.)
Angiomyolipomas of sufficient size may be appreciated on a plain abdominal radiograph or an IV urogram (see Images 3-4, 12). A large, extrarenal, exophytic component is present in 25% of cases; it may be visualized with both a plain abdominal radiograph and an IV urogram. If planar tomographic images are obtained before the administration of IV contrast material and if a large quantity of fat is present within the tumor, radiolucency may be evident. This finding suggests the diagnosis of angiomyolipoma; it is seen in <10% of cases. With multiple large angiomyolipomas, particularly those in patients with tuberous sclerosis, an IV urogram may demonstrate distortion of the renal collecting system that is indistinguishable from polycystic renal disease. On CT scans, calcification is apparent within the tumor in as many as 6% of cases.
Degree of Confidence
Plain radiography and IV urography are not useful in the diagnosis of angiomyolipoma, because neither modality has enough sensitivity to demonstrate fat within the tumor. Moreover, there are other causes of the occurrence of fat within renal masses, although such cases are rare. Multiple angiomyolipomas that distort the collecting system may be indistinguishable from polycystic disease.
False Positives/Negatives
A false-positive diagnosis may occur in cases involving other renal tumors containing fatty tissue. Only larger angiomyolipomas contain a sufficient amount of fat to be visible on plain radiographs.
Computed Tomography
Computed tomography scan obtained in a 15-year-old boy with tuberous sclerosis (under surveillance). The image shows rapid growth in a right renal lesion with mixed attenuation. The final diagnosis was tuberous sclerosis–associated angiomyolipoma.
Computed tomography (CT) scan obtained in the same patient as in Image above. The image shows the technique of CT scanning-guided biopsy with a Tru-cut needle.
Nonenhanced axial computed tomography scan through the kidneys. The image shows a space-occupying lesion of mixed attenuation interspersed with areas of fat attenuation. The final diagnosis was sporadic angiomyolipoma.
Contrast-enhanced axial computed tomography scan obtained through the kidneys in the same patient as in Image above. The image shows patchy tumor enhancement, with displacement of part of the normal lateral aspect of the renal cortex.
Findings
Angiomyolipomas are usually well-marginated, cortical heterogeneous tumors with predominantly fatty attenuation; rarely, higher attenuation is seen in patients who have tumors with minimal fat content. The average attenuation depends on the relative proportions of fat and other soft tissue in the angiomyolipoma. In small masses, fat may be averaged out with region-of-interest (ROI) circles, and pixel maps may be useful. Attenuations of less than –20 Hounsfield units (HU) are widely accepted as confirming the presence of fat; this finding virtually confirms the diagnosis of angiomyolipoma. Nonfatty angiomyolipomas are rare, but renal cell carcinoma may engulf fat. Angiomyolipomas may calcify and cause the HU value to increase out of the range for fat. However, this effect is rare; significant calcification should prompt the reconsideration of angiomyolipoma as a diagnosis.16,17,18,19,20,21,22
The widespread availability of spiral and multisection CT scanning has made the characterization of angiomyolipoma tumors more accurate (see Images 5-10, 13).23 Nonenhanced spiral CT scanning with 5-mm collimation and a pitch of 1.5 that is followed by nephrographic contrast-enhanced phase imaging (120-180 s after injection) is ideal for characterization. It is important to review the nonenhanced images for fat because contrast enhancement averages out the appearance of fat. In small tumors, thin reconstructions may be necessary to optimize fat sensitivity.
In older, nonspiral CT scanners, contiguous 5-mm transaxial sections, imaged both before and after contrast enhancement, are used in the typical examination.24 In smaller lesions, even thinner sections (1.5- or 3.0-mm sections) may be required to improve fat sensitivity. Achieving good fat sensitivity is more difficult with slower scanning times; sensitivity is further limited by breath-hold techniques.
Spiral CT scanning enables continuous scanning of complete anatomic volumes, which is particularly important for the characterization of small angiomyolipomas. Enhancement varies because of the vascular and muscle components. Hemorrhagic, necrotic, and cystic areas, as well as distorted or dilated calyces, contribute to the heterogeneity of these lesions. With CT scanning, particularly spiral and multisection CT scanning, optimal visualization of blood vessels and aneurysms in the vascular phase of the bolus of injected contrast agent may be achieved.
Differentiating angiomyolipoma with minimal fat from a renal cell carcinoma on biphasic CT scanning may be problematic. Kim et al classified the renal tumor enhancement patterns following the administration of iodinated contrast.25
An early washout pattern was considered to be present when a tumor showed peak enhancement in the corticomedullary phase and then demonstrated a washout of at least 20 HU in the early excretory phase; a gradual enhancement pattern was considered to be present when the tumor attenuation value in the early excretory phase was at least 20 HU greater than it was in the corticomedullary phase; and a prolonged enhancement pattern was considered to be present when the difference in tumor attenuation between the corticomedullary and early excretory phases ranged from -20 to 20 HU. The authors found that the most significant predictors of angiomyolipoma with minimal fat were homogeneous enhancement and a prolonged enhancement pattern.
The positive and negative predictive values of homogeneous enhancement for differentiating angiomyolipoma with minimal fat from renal cell carcinoma were 83% and 94%, respectively. For the prolonged enhancement pattern, the positive and negative predictive values were 65% and 88%, respectively. Kim et alconcluded that biphasic helical CT scanning is useful in the differentiation of angiomyolipoma with minimal fat from renal cell carcinoma.25 Homogeneity of tumor enhancement and a prolonged enhancement pattern are the most valuable CT scan findings for differentiating between angiomyolipoma with minimal fat and renal cell carcinoma. Other findings, including tumor attenuation on unenhanced scans, amount of tumor enhancement, intratumoral calcification, and patient sex, provide supplementary information.
Scialpi et al found quantitative analysis of signal intensity variations during dynamic contrast-enhanced MRI with fat suppression useful in the characterization of small renal lesions.26 Angiomyolipomas had an early peak mean percentage of enhancement at 30 s, even though the tumors remained hypointense in comparison with the renal cortex. This finding was caused by the shift from low signal intensity on baseline fat-suppressed sequences to high signal intensity for lesion vascularity as soon as the contrast material (gadolinium) was injected. Subsequently, a vascular washout of gadolinium demonstrated a decline in the percentage of enhancement to values similar to that of hypovascular renal cell carcinomas from 90 to 210 s.
Patel et al studied the radiologic characteristics of renal masses in 12 individuals with tuberous sclerosis complex (TSC).27 Using serial CT scans to examine how renal cell carcinoma may be differentiated from other masses, the authors measured the CT scanning density of all masses and categorized the masses as simple cysts, complex cysts, angiomyolipomas, or indeterminate solid masses. Subjects underwent regular follow-up with repeat CT scans or MRIs and interval renal ultrasonography. Rapidly growing indeterminate masses were considered suspicious for renal cell carcinoma; biopsy or nephrectomy of the masses followed. A median of 4 years of comparative data were available.27
Of the solid masses, 133 were typical angiomyolipomas and 52 were indeterminate. On follow-up, 3 indeterminate masses showed rapid growth (>0.5 cm/y), 1 of which proved to be a renal cell carcinoma on biopsy.The remaining 2 indeterminate masses were found to be minimal-fat angiomyolipomas; the remainder of the masses showed either no growth or slow growth. The authors concluded that many renal masses associated with TSC are radiologically indeterminate. A growth threshold of >0.5cm/y identified the only renal cell carcinoma in the study (0.5% of all masses). Patel et al recommended that individuals with TSC have annual radiologic follow-up of indeterminate renal masses.27
A study assessed the diagnostic accuracy of ROI density measurements and pixel mapping for angiomyolipomas using CT scanning. An ROI threshold value of £10 units was found to have a very high specificity (100%), although the sensitivity was only 73%.28 Pixel mapping was found to be more sensitive for recognizing small clusters of fat; however, the authors recommended that both methods be employed when the diagnosis of angiomyolipomas is suspected.
Simpson and Patel recommended that a diagnostic threshold of ≤-10 units be used for ROI density measurements; this measurement is convenient for analyzing large areas of suspected fat. In cases with small lucent areas or indeterminate values after ROI analysis, pixel mapping is recommended; the recommended discriminating threshold is a line of 4 pixels £ -10 units or a square of 4 pixels £ -10 units.
Degree of Confidence
The characterization of angiomyolipomas with CT is dependent on spatial resolution and accurate determination of attenuation values; newer spiral scanners meet these criteria. As a result, CT scanning is highly accurate in the characterization and diagnosis of angiomyolipoma lesions.23
False Positives/Negatives
When negative attenuation values of less than 20 HU are recorded in renal tumors, angiomyolipomas may be reliably diagnosed in the appropriate clinical setting, and the diagnosis of a renal cell carcinoma can generally be ruled out. However, isolated reports of renal cell carcinoma with demonstrable fat content have appeared in the literature. These renal carcinomas may entrap surrounding perinephric fat or undergo fatty change because of metaplasia. Intratumoral fat is also reported in Wilms tumors, oncocytoma, xanthogranulomatous pyelonephritis, renal and retroperitoneal liposarcoma, and teratoma. A false-negative diagnosis is made in the 5% of patients with angiomyolipomas that contain only microscopically visible fat.
Magnetic Resonance Imaging
Findings
The characteristic appearances of angiomyolipomas with MRI include variable areas of high signal intensity within the tumor on both T1-weighted and T2-weighted images. On a nonenhanced T1-weighted image, high signal intensity is present because of the fat content. On T2-weighted images, the signal remains isointense relative to that of perinephric fat. However, areas of high signal intensity on T1-weighted images are not pathognomonic of fat, and blood and pockets of fluid of high protein content may have a similar appearance. Intratumoral fat is best demonstrated with fat-suppression techniques. The in-phase and out-of-phase T1-weighted imaging technique is extremely sensitive to small quantities of fat.29 MRI studies may show the rare complication of regional lymph node involvement and invasion of the renal vein and IVC.
On MRI, changes in signal intensity that occur as a result of the intrinsic differences in the resonant frequencies of precessing protons are known as the chemical shift phenomenon.30,31 This phenomenon has been used as a diagnostic tool; by demonstrating the inherent differences in resonant frequencies of fatty tissue and water, lipid-containing tumors may be identified. Although some success has been achieved in the diagnosis of fatty tumors such as angiomyolipomas, chemical shift (in-phase and out-of-phase imaging) probably is less likely to depict fat in an angiomyolipoma, because fat is macroscopic; chemical shift imaging is more likely to demonstrate microscopic fat, such as that in a renal cell carcinoma. A standard chemically selective fat-saturated technique better depicts the signal-intensity dropout of fat in an angiomyolipoma because this technique better depicts macroscopic fat.
Traditionally, angiomyolipoma has been diagnosed by comparing T1-weighted images incorporating frequency-selective fat suppression with T1-weighted images without frequency-selective fat suppression. Angiomyolipomas may also be diagnosed using opposed-phase chemical shift artifact. Israel et al investigated the use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipoma.32
Two types of edge artifacts have been described with chemical shift MRI: the chemical shift artifact and the India ink artifact. The chemical shift artifact is dependent on the receiver bandwidth and the shape and orientation of the fat–water interface. The India ink artifact is caused by the presence of fat and water protons within the same imaging voxel; this results in signal loss. The India ink artifact may be recognized on opposed-phase MRIs as a characteristic sharp black line at fat–water interfaces. Because the India ink artifact is a result of fat- and water-proton phase cancellation in all directions, the artifact occurs along the entire border of fat–water interface, not only in the frequency-encoding direction.
In addition, because most angiomyolipomas contain macroscopic fat, the India ink artifact appears at all interfaces of the tumor with the kidney or at the interfaces of the fatty and nonfatty portions of the mass. Other renal masses do not contain macroscopic fat; for that reason, the India ink artifact appears at the interface of the renal mass with perinephric fat when the mass is exophytic. Thus, the diagnosis of angiomyolipoma is indicated when the India ink artifact is present at a renal mass–kidney interface or within a renal mass.
Degree of Confidence
Because of its wide availability, CT remains the modality of choice for the detection of fat in renal tumors.
False Positives/Negatives
Hemorrhagic cysts and cysts with a high protein content may mimic fat within renal tumors.
Ultrasonography
Renal ultrasonogram obtained in a 12-year-old boy with known tuberous sclerosis. Note the multiple echogenic tumors of varying sizes in both kidneys (see also Images below). This oblique sagittal scan through the left kidney shows a 4-cm echogenic mass (arrow) on the inferior aspect of the kidney that anteriorly displaces the renal sinus (S).
Renal ultrasonogram depicting many tumors in the right kidney. The arrow marks an echogenic 1-cm lesion. (Image above and 2 below were obtained in the same patient.)
Selective right renal angiogram showing multiple avascular tumors. The tumors are small. (Images above and one below were obtained in the same patient.)
Selective left renal angiogram showing 2 tumors, which are larger than those in Image 3. The final diagnosis was multiple renal angiomyolipomas in a patient with tuberous sclerosis. (Images above were obtained in the same patient.)
Findings
Renal angiomyolipomas are intensely echogenic and may cause acoustic shadowing (see Images 1-2, 11, 14).13 They are round or oval cortical tumors; they tend to be well circumscribed, with an echogenicity similar to that of the echogenic renal sinus. Because of their intense echogenicity, angiomyolipomas as small as a few millimeters in diameter may be identified. Less echogenic areas within the tumor are related to hemorrhage, necrosis, or dilated calyces. A reduction of echogenicity in angiomyolipomas is thought to be related to a decrease in the quantity of fat and to an increase in the prominence of myogenic components. Doppler ultrasonography may be used to confirm the rare complication of extension into the renal vein and the IVC.
Degree of Confidence
Marked echogenicity in a renal mass is not pathognomonic of angiomyolipomas. Other tumors, including renal cell carcinoma, may be hyperechoic. Tumors that are echogenic on ultrasonograms should be further investigated with CT scans, and the fat content of the tumor should be assessed.
False Positives/Negatives
A false-negative diagnosis may occur in cases involving a hemorrhagic or infarcted tumor, as well as in cases involving a tumor that has little fat. Also, a scar in the periphery of the kidney may be filled with intraperitoneal or omental fat; such a scar may have ultrasonographic features typical of an angiomyolipoma.
The differential diagnosis of a hyperechoic renal tumor includes the following:
- Angiomyolipoma
- Renal cell carcinoma
- Liposarcoma
- Atypical Wilms tumor
- Lipoma
- Oncocytoma
- Cavernous hemangioma
- Renal infarction
- Renal sinus
- Lipomatosis
- Fat-filled postoperative renal cortical defects
See Other Problems To Be Considered, above.
Nuclear Imaging
Findings
The role of nuclear medicine is restricted to isotope renography with technetium-99m (99m Tc) mercaptoacetythiglycine (MAG3) to assess relative renal function before nephron-sparing surgery.99m Tc DMSA scanning may be used to assess differential renal function;99m Tc DMSA may be more useful in differentiating true masses and pseudomasses in cases in which other imaging findings are equivocal.
Angiography
Findings
Before the advent of ultrasonography, CT scanning, and MRI, much effort went into identifying angiographic characteristics that allow angiomyolipomas to be distinguished from renal cell carcinoma. Among radiologists, there is controversy regarding the reliability of angiography in the differentiation of these tumors.
About 95% of angiomyolipomas are hypervascular, with enlarged interlobar and interlobular arteries. The intratumoral arteries are tortuous, irregular, and aneurysmal. Venous pooling has a sunburst, whorled, and onion-peel appearance. Usually, no arteriovenous (AV) shunting is present. The following findings suggest an angiomyolipoma: the presence of multisacculated pseudoaneurysms; a sunburst appearance on the capillary nephrogram; an onion-skin appearance of the peripheral vessels in the venous phase; and the absence of AV shunting.
Degree of Confidence
CT scanning has superseded angiography as a diagnostic tool; CT scanning is noninvasive, its results are more reproducible, and it is less dependent on operator technique and interpretation. Currently, angiography is reserved for use in transcatheter embolization to control bleeding caused by angiomyolipomas.
False Positives/Negatives
A significant finding in cases of angiomyolipoma is the lack of AV shunting on angiograms. However, AV shunting has been reported in cases of angiomyolipoma; therefore, it cannot be used to distinguish an angiomyolipoma from renal cell carcinoma. A reduction in the blood flow of a mass in response to epinephrine is characteristic of a benign lesion. The absence of this reduction in response to epinephrine was thought to be specific for malignant tumors, but such reduction in blood flow has been demonstrated to occur in cases of angiomyolipoma.
More on Angiomyolipoma, Kidney |
| Overview: Angiomyolipoma, Kidney |
 Imaging: Angiomyolipoma, Kidney |
| Follow-up: Angiomyolipoma, Kidney |
| Multimedia: Angiomyolipoma, Kidney |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int. Nov 2006;70(10):1777-82. [Medline].
Blute ML, Malek RS, Segura JW. Angiomyolipoma: clinical metamorphosis and concepts for management. J Urol. Jan 1988;139(1):20-4. [Medline].
Cohen MD. Genitourinary tumors. In: Cohen MD, ed. Imaging of Children With Cancer. St Louis, Mo: Mosby Year Book; 1992:552-88.
Baert J, Vandamme B, Sciot R, et al. Benign angiomyolipoma involving the renal vein and vena cava as a tumor thrombus: case report. J Urol. Apr 1995;153(4):1205-7. [Medline].
Ricketts R, Tamboli P, Czerniak B, Guo CC. Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med. Jun 2008;132(6):1016-20. [Medline].
Williams TR, Oakes MF. Metastatic breast carcinoma to renal angiomyolipomas in tuberous sclerosis. Urology. Feb 2008;71(2):352.e5-7. [Medline].
Dähnert W. Radiology Review Manual. 4th ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999:761.
Quicios Dorado C, Allona Almagro A. [Renal angiomyolipoma causing inferior vena cava thrombus and secondary Budd-Chiari's syndrome]. Arch Esp Urol. Apr 2008;61(3):435-9. [Medline].
Sato K, Ueda Y, Tachibana H, Miyazawa K, Chikazawa I, Kaji S, et al. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: An autopsy case report with p53 gene mutation analysis. Pathol Res Pract. Jun 9 2008;[Medline].
Earthman WJ, Mazer MJ, Winfield AC. Angiomyolipomas in tuberous sclerosis: subselective embolotherapy with alcohol, with long-term follow-up study. Radiology. Aug 1986;160(2):437-41. [Medline].
Steiner MS, Goldman SM, Fishman EK, Marshall FF. The natural history of renal angiomyolipoma. J Urol. Dec 1993;150(6):1782-6. [Medline].
Kutikov A, Fossett LK, Ramchandani P, Tomaszewski JE, Siegelman ES, Banner MP. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. Oct 2006;68(4):737-40. [Medline].
Siegel CL, Middleton WD, Teefey SA, McClennan BL. Angiomyolipoma and renal cell carcinoma: US differentiation. Radiology. Mar 1996;198(3):789-93. [Medline].
Forman HP, Middleton WD, Melson GL, McClennan BL. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology. Aug 1993;188(2):431-4. [Medline].
Surabhi VR, Menias C, Prasad SR, Patel AH, Nagar A, Dalrymple NC. Neoplastic and non-neoplastic proliferative disorders of the perirenal space: cross-sectional imaging findings. Radiographics. Jul-Aug 2008;28(4):1005-17. [Medline].
Helenon O, Merran S, Paraf F, et al. Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics. Jan-Feb 1997;17(1):129-44. [Medline].
Strotzer M, Lehner KB, Becker K. Detection of fat in a renal cell carcinoma mimicking angiomyolipoma. Radiology. Aug 1993;188(2):427-8. [Medline].
Kurosaki Y, Tanaka Y, Kuramoto K, Itai Y. Improved CT fat detection in small kidney angiomyolipomas using thin sections and single voxel measurements. J Comput Assist Tomogr. Sep-Oct 1993;17(5):745-8. [Medline].
Lemaitre L, Robert Y, Dubrulle F, et al. Renal angiomyolipoma: growth followed up with CT and/or US. Radiology. Dec 1995;197(3):598-602. [Medline].
Mitchell TL, Pippin JJ, Devers SM, et al. Incidental detection of preclinical renal tumors with electron beam computed tomography: report of 26 consecutive operated patients. J Comput Assist Tomogr. Nov-Dec 2000;24(6):843-5. [Medline].
Ellingson JJ, Coakley FV, Joe BN, Qayyum A, Westphalen AC, Yeh BM. Computed tomographic distinction of perirenal liposarcoma from exophytic angiomyolipoma: a feature analysis study. J Comput Assist Tomogr. Jul-Aug 2008;32(4):548-52. [Medline].
Kim JY, Kim JK, Kim N, Cho KS. CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging. Radiology. Feb 2008;246(2):472-9. [Medline].
Silverman SG, Pearson GD, Seltzer SE, Polger M, Tempany CM, Adams DF, et al. Small (< or = 3 cm) hyperechoic renal masses: comparison of helical and convention CT for diagnosing angiomyolipoma. AJR Am J Roentgenol. Oct 1996;167(4):877-81. [Medline].
Bosniak MA, Megibow AJ, Hulnick DH, et al. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol. Sep 1988;151(3):497-501. [Medline].
Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology. Mar 2004;230(3):677-84. [Medline]. [Full Text].
Scialpi M, Di Maggio A, Midiri M, Loperfido A, Angelelli G, Rotondo A. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. AJR Am J Roentgenol. Sep 2000;175(3):751-7. [Medline]. [Full Text].
Patel U, Simpson E, Kingswood JC, Saggar-Malik AK. Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol. Jun 2005;60(6):665-73; discussion 663-4. [Medline].
Simpson E, Patel U. Diagnosis of angiomyolipoma using computed tomography-region of interest < or =-10 HU or 4 adjacent pixels < or = -10 HU are recommended as the diagnostic thresholds. Clin Radiol. May 2006;61(5):410-6. [Medline].
Martin J, Puig J, Falco J, et al. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging. Radiology. May 1998;207(2):325-30. [Medline].
Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. Radiographics. Mar-Apr 1999;19(2):357-71. [Medline]. [Full Text].
Kido T, Yamashita Y, Sumi S, et al. Chemical shift GRE MRI of renal angiomyolipoma. J Comput Assist Tomogr. Mar-Apr 1997;21(2):268-70. [Medline].
Israel GM, Hindman N, Hecht E, Krinsky G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol. Jun 2005;184(6):1868-72. [Medline].
Zardawi IM. Renal fine needle aspiration cytology. Acta Cytol. Mar-Apr 1999;43(2):184-90. [Medline].
Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J. Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol. Sep 2006;187(3):762-8. [Full Text].
Chiang IC, Jang MY, Tsai KB, Hsieh TJ. Huge renal lipoma with prominent hypervascular non-adipose elements. Br J Radiol. Oct 2006;79(946):e148-51. [Medline].
Prevoo W, van den Bosch MA, Horenblas S. Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology. Jul 2008;72(1):188-91. [Medline].
Byrd GF, Lawatsch EJ, Mesrobian HG, Begun F, Langenstroer P. Laparoscopic cryoablation of renal angiomyolipoma. J Urol. Oct 2006;176(4 Pt 1):1512-6; discussion 1516. [Medline].
Juul N, Torp-Pedersen S, Grønvall S, Holm HH, Koch F, Larsen S. Ultrasonically guided fine needle aspiration biopsy of renal masses. J Urol. Apr 1985;133(4):579-81. [Medline].
Ditonno P, Smith RB, Koyle MA, et al. Extrarenal angiomyolipomas of the perinephric space. J Urol. Feb 1992;147(2):447-50. [Medline].
Lemaitre L, Claudon M, Dubrulle F, Mazeman E. Imaging of angiomyolipomas. Semin Ultrasound CT MR. Apr 1997;18(2):100-14. [Medline].
Paivansalo M, Lahde S, Hyvarinen S, et al. Renal angiomyolipoma. Ultrasonographic, CT, angiographic, and histologic correlation. Acta Radiol. May 1991;32(3):239-43. [Medline].
Tello R, Blickman JG, Buonomo C, Herrin J. Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol. May 1998;27(2):131-8. [Medline].
Further Reading
Related eMedicine topics
Kidney, Lymphoma
Autosomal Dominant Polycystic Kidney Disease
Autosomal Recessive Polycystic Kidney Disease
Guidelines and clinical studies
ACR Appropriateness Criteria® indeterminate renal masses. American College of Radiology. 1996 (revised 2007). 7 pages. NGC:005996
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
Keywords
angiomyolipoma of the kidney, benign mesenchymal tumor of the kidney, renal choristoma, renal hamartoma, isolated angiomyolipoma, tuberous sclerosis
